EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · IEX Real-Time Price · USD
21.28
-1.17 (-5.21%)
At close: Apr 15, 2024, 4:00 PM
21.35
+0.07 (0.33%)
After-hours: Apr 15, 2024, 6:50 PM EDT
EyePoint Pharmaceuticals Market Cap
EyePoint Pharmaceuticals has a market cap or net worth of $1.06 billion as of April 15, 2024. Its market cap has increased by 921.58% in one year.
Market Cap
1.06B
Enterprise Value
734.11M
1-Year Change
921.58%
Ranking
Category
Stock Price
$21.28
Market Cap Chart
Since January 27, 2005, EyePoint Pharmaceuticals's market cap has increased from $388.60M to $1.06B, an increase of 172.88%. That is a compound annual growth rate of 5.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 12, 2024 | 1.12B | -1.92% |
| Apr 11, 2024 | 1.14B | 5.44% |
| Apr 10, 2024 | 1.08B | 0.83% |
| Apr 9, 2024 | 1.07B | 3.86% |
| Apr 8, 2024 | 1.03B | 2.22% |
| Apr 5, 2024 | 1.01B | 0.65% |
| Apr 4, 2024 | 1.00B | -2.89% |
| Apr 3, 2024 | 1.03B | 2.32% |
| Apr 2, 2024 | 1.01B | 0.05% |
| Apr 1, 2024 | 1.01B | -1.93% |
| Mar 28, 2024 | 1.03B | -0.68% |
| Mar 27, 2024 | 1.04B | 0.88% |
| Mar 26, 2024 | 1.03B | -4.89% |
| Mar 25, 2024 | 1.08B | -2.56% |
| Mar 22, 2024 | 1.11B | -4.95% |
| Mar 21, 2024 | 1.17B | 0.30% |
| Mar 20, 2024 | 1.16B | 5.65% |
| Mar 19, 2024 | 1.10B | 3.76% |
| Mar 18, 2024 | 1.06B | -0.84% |
| Mar 15, 2024 | 1.07B | -1.19% |
| Mar 14, 2024 | 1.08B | -1.59% |
| Mar 13, 2024 | 1.10B | -3.15% |
| Mar 12, 2024 | 1.14B | -0.26% |
| Mar 11, 2024 | 1.14B | -6.28% |
| Mar 8, 2024 | 1.22B | 36.05% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcutis Biotherapeutics | 1.17B |
| AtriCure | 1.17B |
| Mirum Pharmaceuticals | 1.15B |
| Collegium Pharmaceutical | 1.14B |
| MannKind | 1.12B |
| Centessa Pharmaceuticals | 1.12B |
| Maravai LifeSciences Holdings | 1.11B |
| Belite Bio | 1.10B |